The use of renin angiotensin aldosterone system inhibitors may be associated with decreased mortality after cancer surgery

HIGHLIGHTS

• who: Ah Ran Oh from the DepartmentSungkyunkwan University have published the research: The use of renin angiotensin aldosterone system inhibitors may be associated with decreased mortality after cancer surgery, in the Journal: Scientific Reports Scientific Reports
• what: This study was conducted in compliance with the declaration of Helsinki and was reported according to the Strengthening the Reporting of Observational studies in Epidemiology guideline. The present analysis showed that RAAS inhibitors` postoperative use was associated with decreased mortality and recurrence rate after cancer surgery except for the 1-year recurrence rate. To explain this favorable effect . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.